Clinical Trials Directory

Trials / Completed

CompletedNCT04788719

Pre and Postoperative Gait Analysis of Randomized Patient to 2 Different Cement Fixation Methods

Pre and Postoperative Gait Analysis of Randomized Patients to 2 Different Cement Fixation Methods

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Göteborg University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The primary goal of Total Hip Replacement (THR) surgery in the treatment of hip osteoarthritis is to reduce pain and restore hip function in order to increase patient mobility and quality of life. Two different cement fixation methods are used in order to insert THR implants. This will be done before and after surgery in 2 groups randomized to either of 2 cement fixation methods. Gait analysis preoperative and 2 year after surgery.

Detailed description

The primary goal of Total Hip Replacement (THR) surgery in the treatment of hip osteoarthritis is to reduce pain and restore hip function in order to increase patient mobility and quality of life. Patients with radiological signs of osteoarthritis of the hip, hip pain and functional disability may be treated with insertion of a THA. Two different fixation methods are used in order to insert THR implants. Cemented fixation using bone cement, polymethyl methacrylate (PMMA) is the most commonly used fixation method in Sweden. A new bone cement, Refobacin®, already marketed in Germany is planned to be introduced in Sweden in late 2018. The hospital is also equipped with a modern gait laboratory were the functional gait performance can be evaluated. This will be done before and after surgery in 2 groups randomized to either of 2 cement fixation methods. The subjects will undergo gait analysis befor and 2 year after surgery.

Conditions

Interventions

TypeNameDescription
OTHERGait analysisGait analysis

Timeline

Start date
2018-01-01
Primary completion
2020-01-01
Completion
2021-03-01
First posted
2021-03-09
Last updated
2021-09-09

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT04788719. Inclusion in this directory is not an endorsement.